Meds raised a new round of $4.3M

Meds, a Stockholm, Sweden-based company managing an online pharmarcy operation, completed a SEK 42M ($4.3M) capital investment round.

The funding was provided by existing investors.

Meds was founded in 2017 by CEO Björn Thorngren with the aim to contribute to the liberalised local market of prescription drugs. The company had sales of SEK 25 million ($2.6M) in 2018 and expects to to get to SEK 100 million at the end of 2019.

This is the second round announced in 2019, after having raised $5.6M from Inbox Capital in January.